A retrospective study finds that low-dose doxycycline is as effective as high-dose for lymphocytic scarring alopecia while ...

If you just entered menopause, you’re experiencing plenty of changes, from sleep disruptions to hormonal changes that prompt ...

Alopecia areata is a skin disease that makes you lose patches or large sections of hair on your scalp and body. It's not life-threatening, but it can be life-altering. Hair is a part of your identity.

If you have alopecia areata, you are probably no stranger to a roller coaster of emotions. It’s true that this condition isn’t life-threatening and doesn't cause physical pain. But it can ...

Significantly more adolescent patients receiving baricitinib had hair regrowth compared with patients receiving placebo.

Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.

For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 mg is efficacious and tolerable.

placebo in adults with severe alopecia areata, according to phase 3 data presented here. Oral ivarmacitinib significantly induced hair regrowth at 24 weeks compared with placebo in adults with ...

Patients with severe to very severe alopecia areata saw hair regrowth with bempikibart treatment within 24 weeks. Hair regrowth seemed to persist after treatment cessation to week 36. ORLANDO ...

HealthDay News — For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8mg is efficacious and tolerable, according to a study ...

have developed a compound that could potentially treat the autoimmune disorder alopecia areata, which causes hair loss leading to the formation of bald patches. The results of their study, recently ...

For adolescents with severe alopecia areata (AA), baricitinib is efficacious for hair regrowth, according to a study ...